Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-08 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |